Skip to main content
Erschienen in: Clinical Research in Cardiology 1/2016

01.01.2016 | Original Paper

Safety of symptom-limited exercise testing in a big cohort of a modern ICD population

verfasst von: Frederik Voss, Melanie Schueler, Michael Lauterbach, Alexander Bauer, Hugo A. Katus, Ruediger Becker

Erschienen in: Clinical Research in Cardiology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Exercise may predispose to ventricular arrhythmias especially in patients with congestive heart failure. As therapy with implanted cardioverter-defibrillators (ICDs) has become standard medical care, there is an emerging number of exercise tests that need to be performed in patients with ICDs. In contrast, little is known about the safety of symptom-limited exercise testing in these patients.

Methods and results

400 ICD patients performed symptom-limited exercise treadmill testing. 200 patients performed a ramp protocol with an initial workload of 0 W increased by 15 W every minute. Another 200 ICD patients did a slightly modified ramp protocol with again an initial workload of 0 W but with an increased capacity of 15 W every 2 min. The study population consists mainly of patients with ischemic (63 %) and non-ischemic (34 %) heart disease. Atrial fibrillation was present in 16 % of the subjects. The mean ejection fraction was 28 ± 8, and 78 % of the patients had an ejection fraction below 30 %. In this cohort of patients, no sustained ventricular arrhythmias and no deaths occurred during or after exercise testing. No inappropriate shock delivery was observed. The modified ramp protocol resulted in a prolonged exercise time with equal exercise capacity but does not result in an enhanced susceptibility for ventricular arrhythmias.

Conclusions

Symptom-limited exercise treadmill testing in heart failure patients with ICDs is a safe procedure. The use of a ramp protocol is sufficient in terms of safety and is easy to perform in general practice. The exercise duration in heart failure patients with ICDs does not predict serious adverse events.
Literatur
1.
Zurück zum Zitat Kadish A, Dryer A, Daubert JP et al (2004) Prophylactic cardioverter-defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158PubMedCrossRef Kadish A, Dryer A, Daubert JP et al (2004) Prophylactic cardioverter-defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158PubMedCrossRef
2.
Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRef Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, for the Multicenter Automatic Defibrillator Implantation Trial Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRef
3.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Bioneau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237PubMedCrossRef Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Bioneau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237PubMedCrossRef
4.
Zurück zum Zitat Antiarrhythmic The, versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRef Antiarrhythmic The, versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRef
5.
Zurück zum Zitat Connolly SJ, Gent M, Roberts RS, for the CIDS Investigators et al (2000) Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302PubMedCrossRef Connolly SJ, Gent M, Roberts RS, for the CIDS Investigators et al (2000) Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297–1302PubMedCrossRef
6.
Zurück zum Zitat Kuck KH, Cappato R, Siebels J, Rüppel R, for the CASH Investigators (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754PubMedCrossRef Kuck KH, Cappato R, Siebels J, Rüppel R, for the CASH Investigators (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 102:748–754PubMedCrossRef
7.
Zurück zum Zitat Franklin BA (1995) Diagnostic and functional exercise testing: test selection and interpretation. J Cardiovasc Nurs 10:8–25PubMedCrossRef Franklin BA (1995) Diagnostic and functional exercise testing: test selection and interpretation. J Cardiovasc Nurs 10:8–25PubMedCrossRef
8.
Zurück zum Zitat Ades PA (2001) Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345:892–902PubMedCrossRef Ades PA (2001) Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345:892–902PubMedCrossRef
9.
Zurück zum Zitat Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology (2001) Recommendations for exercise training in chronic heart failure patients. Eur Heart J 22:125–135CrossRef Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology (2001) Recommendations for exercise training in chronic heart failure patients. Eur Heart J 22:125–135CrossRef
10.
Zurück zum Zitat Flo GL, Glenny RW, Kudenchuk PJ, Dougherty CM (2012) Development and safety of an exercise testing protocol for patients with an implanted cardioverter defibrillator for primary and secondary indication. Cardiopulm Phys Ther J 23:16–22PubMedPubMedCentral Flo GL, Glenny RW, Kudenchuk PJ, Dougherty CM (2012) Development and safety of an exercise testing protocol for patients with an implanted cardioverter defibrillator for primary and secondary indication. Cardiopulm Phys Ther J 23:16–22PubMedPubMedCentral
11.
Zurück zum Zitat Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C (2008) Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators. Arch Gen Psychiatry 65:1324–1330PubMedCrossRef Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C (2008) Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators. Arch Gen Psychiatry 65:1324–1330PubMedCrossRef
12.
Zurück zum Zitat Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017PubMedPubMedCentralCrossRef Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Kelly TM (1996) Exercise testing and training of patients with malignant ventricular arrhythmias. Med Sci Sports Exerc 28:53–61PubMedCrossRef Kelly TM (1996) Exercise testing and training of patients with malignant ventricular arrhythmias. Med Sci Sports Exerc 28:53–61PubMedCrossRef
14.
Zurück zum Zitat Vanhees L, Kornaat M, Deforr J, Aufdemkampe G, Schepers D, Stevens A, van Exel H, van den Beld J, Heidbüchel H, Fagard R (2004) Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 25:1120–1126PubMedCrossRef Vanhees L, Kornaat M, Deforr J, Aufdemkampe G, Schepers D, Stevens A, van Exel H, van den Beld J, Heidbüchel H, Fagard R (2004) Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 25:1120–1126PubMedCrossRef
15.
Zurück zum Zitat Vanhees L, Schepers D, Heidbüchel H, Defoor J, Fagard R (2001) Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease. Am J Cardiol 87:712–715PubMedCrossRef Vanhees L, Schepers D, Heidbüchel H, Defoor J, Fagard R (2001) Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease. Am J Cardiol 87:712–715PubMedCrossRef
16.
Zurück zum Zitat Whang W, Mittleman MA, Rich DQ, Wang PF, Ruskin JN, Tofler GH, Muller JE, Albert CM (2004) Heart failure and risk of shocks in patients with implantable cardioverter defibrillators: results from the triggers of ventricular arrhythmias (TOVA) study. Circulation 109:1386–1391PubMedCrossRef Whang W, Mittleman MA, Rich DQ, Wang PF, Ruskin JN, Tofler GH, Muller JE, Albert CM (2004) Heart failure and risk of shocks in patients with implantable cardioverter defibrillators: results from the triggers of ventricular arrhythmias (TOVA) study. Circulation 109:1386–1391PubMedCrossRef
17.
Zurück zum Zitat Chinnaiyan KM, Trivax J, Franklin BA, Williamson B, Kahn JK (2007) Stress testing in patients with implantable cardioverter-defibrillators: a preliminary report. Prev Cardiol 10:92–95PubMedCrossRef Chinnaiyan KM, Trivax J, Franklin BA, Williamson B, Kahn JK (2007) Stress testing in patients with implantable cardioverter-defibrillators: a preliminary report. Prev Cardiol 10:92–95PubMedCrossRef
18.
Zurück zum Zitat Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE, HF-ACTION investigators (2009) Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular dysfunction. Am Heart J 158:S72–S77PubMedPubMedCentralCrossRef Keteyian SJ, Isaac D, Thadani U, Roy BA, Bensimhon DR, McKelvie R, Russell SD, Hellkamp AS, Kraus WE, HF-ACTION investigators (2009) Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular dysfunction. Am Heart J 158:S72–S77PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Young DZ, Lampert S, Graboys TB, Lown B (1984) Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. Circulation 70:184–191PubMedCrossRef Young DZ, Lampert S, Graboys TB, Lown B (1984) Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. Circulation 70:184–191PubMedCrossRef
20.
Zurück zum Zitat Gibbons L, Blair SN, Kohl HW, Cooper K (1989) The safety of maximal exercise testing. Circulation 80:846–852PubMedCrossRef Gibbons L, Blair SN, Kohl HW, Cooper K (1989) The safety of maximal exercise testing. Circulation 80:846–852PubMedCrossRef
21.
Zurück zum Zitat Lampert R, Cannom D, Olshansky B (2006) Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of Heart Rhythm Society memebers. J Cardiovasc Electrophysiol 17:11–15PubMedCrossRef Lampert R, Cannom D, Olshansky B (2006) Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of Heart Rhythm Society memebers. J Cardiovasc Electrophysiol 17:11–15PubMedCrossRef
22.
Zurück zum Zitat Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE (2000) Triggering of sudden cardiac death from cardiac causes by vigorous exertion. N Engl J Med 343:1313–1375CrossRef Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE (2000) Triggering of sudden cardiac death from cardiac causes by vigorous exertion. N Engl J Med 343:1313–1375CrossRef
23.
Zurück zum Zitat Do D, West JA, Morise A, Atwood E, Froelicher V (1997) A consensus approach diagnosing coronary artery disease based on clinical and exercise test data. Chest 111:1742–1749PubMedCrossRef Do D, West JA, Morise A, Atwood E, Froelicher V (1997) A consensus approach diagnosing coronary artery disease based on clinical and exercise test data. Chest 111:1742–1749PubMedCrossRef
Metadaten
Titel
Safety of symptom-limited exercise testing in a big cohort of a modern ICD population
verfasst von
Frederik Voss
Melanie Schueler
Michael Lauterbach
Alexander Bauer
Hugo A. Katus
Ruediger Becker
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 1/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-015-0885-5

Weitere Artikel der Ausgabe 1/2016

Clinical Research in Cardiology 1/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.